Loading company…
San Francisco company developing next-generation probiotics for gut health and metabolic support, including for type 2 diabetes.
Pendulum Therapeutics makes probiotics including Glucose Control, which is clinically shown to enhance A1C levels in people with type 2 diabetes, along with Metabolic Daily and Akkermansia. It sells subscriptions direct to consumers and works with healthcare professionals. Founded in 2013 in San Francisco by Colleen Cutcliffe, James Bullard, and John Eid, the company has completed six deals and raised USD 10 mn in a 2023 round to support product development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in